| [Accepted Manuscript] Impact of routine cryptococcal antigen screening and targeted pre-emptive fluconazole therapy in antiretroviral naive HIV-infected adults with less than … E Temfack, JJ Bigna, HN Luma, R Spijker, G Meintjes, JN Jarvis, ... Clinical infectious diseases, 2018 | | 2018 |
| [Accepted Manuscript] Short Course High-dose Liposomal Amphotericin B for HIV-associated Cryptococcal Meningitis: A phase-II Randomized Controlled Trial. JN Jarvis, TB Leeme, M Molefi, AA Chofle, G Bidwell, K Tsholo, N Tlhako, ... Clinical infectious diseases, 2018 | 1 | 2018 |
| 19 The dynamics of trust and structural coercion within a meningitis trial in sub-Saharan Africa D Lawrence, A Ssali, K Tsholo, J Jarvis, J Seeley BMJ Open 11 (Suppl 1), 2021 | | 2021 |
| A Diagnostic Headache N Feasey, J Jarvis, CA Cosgrove, DC Macallan Journal of Infection 54 (3), e200-e201, 2007 | | 2007 |
| A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis AT Jackson, JC Nussbaum, J Phulusa, D Namarika, M Chikasema, ... Aids 26 (11), 1363-1370, 2012 | 102 | 2012 |
| A population genomics approach to assessing the genetic basis of within-host microevolution underlying recurrent cryptococcal meningitis infection J Rhodes, MA Beale, M Vanhove, JN Jarvis, S Kannambath, JA Simpson, ... G3: Genes, Genomes, Genetics 7 (4), 1165-1176, 2017 | 92 | 2017 |
| A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence … M Alufandika, DS Lawrence, T Boyer-Chammard, C Kanyama, ... Aids 34 (9), 1425-1428, 2020 | 11 | 2020 |
| A tale of two countries: progress towards UNAIDS 90‐90‐90 targets in Botswana and Australia T Marukutira, M Stoové, S Lockman, LA Mills, T Gaolathe, R Lebelonyane, ... African Journal of Reproduction and Gynaecological Endoscopy 21 (3), 2018 | 34 | 2018 |
| Accuracy of point-of-care HIV and CD4 field testing by lay healthcare workers in the Botswana Combination Prevention Project EC Bile, PJ Bachanas, JN Jarvis, F Maurice, V Makovore, L Chebani, ... Journal of Virological Methods 311, 114647, 2023 | | 2023 |
| Acute schistosomiasis in travelers: 14 years' experience at the Hospital for Tropical Diseases, London S Logan, M Armstrong, E Moore, G Nebbia, J Jarvis, M Suvari, J Bligh, ... The American journal of tropical medicine and hygiene 88 (6), 1032, 2013 | 34 | 2013 |
| Addition of flucytosine to fluconazole for the treatment of cryptococcal meningitis in Africa: a multicountry cost-effectiveness analysis T Shiri, A Loyse, L Mwenge, T Chen, S Lakhi, D Chanda, P Mwaba, ... Clinical infectious diseases 70 (1), 26-29, 2020 | 16 | 2020 |
| Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial JN Jarvis, G Meintjes, K Rebe, GN Williams, T Bicanic, A Williams, ... Aids 26 (9), 1105-1113, 2012 | 306 | 2012 |
| Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases JN Jarvis, G Meintjes, A Williams, Y Brown, T Crede, TS Harrison BMC infectious diseases 10, 1-6, 2010 | 308 | 2010 |
| Advanced HIV as a Neglected Disease N Ford, P Ehrenkranz, J Jarvis New England Journal of Medicine, 2024 | 1 | 2024 |
| Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis. MW Tenforde, M Mokomane, T Leeme, RKK Patel, N Lekwape, ... Clinical infectious diseases, 2017 | 16 | 2017 |
| Advanced HIV disease in the Botswana combination prevention project: prevalence, risk factors, and outcomes R Lebelonyane, LA Mills, C Mogorosi, F Ussery, T Marukutira, J Theu, ... Aids 34 (15), 2223-2230, 2020 | 16 | 2020 |
| Advanced human immunodeficiency virus disease in Botswana following successful antiretroviral therapy rollout: incidence of and temporal trends in cryptococcal meningitis MW Tenforde, M Mokomane, T Leeme, RKK Patel, N Lekwape, ... Clinical infectious diseases 65 (5), 779-786, 2017 | 59 | 2017 |
| Advances in treatment of cryptococcal meningitis J Jarvis JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 5-6, 2022 | | 2022 |
| AMBIsome Therapy Induction OptimisatioN (AMBITION): high dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a … PL Ponatshego, DS Lawrence, N Youssouf, SF Molloy, M Alufandika, ... BMJ open 9 (4), e026288, 2019 | 7 | 2019 |
| AMBIsome Therapy Induction OptimisatioN (AMBITION): high dose ambisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a phase 3 … DS Lawrence, N Youssouf, SF Molloy, A Alanio, M Alufandika, ... Trials 19, 1-13, 2018 | 41 | 2018 |
Thomas S HarrisonSt Georges University of London在 sgul.ac.uk 的电子邮件经过验证
